Introduction: What Wegovy Is and How It Works
Wegovy (semaglutide) is an FDA-approved prescription medication for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition, such as type 2 diabetes, high blood pressure, or dyslipidemia. It mimics the hormone GLP-1 to reduce hunger, increase fullness, and stabilize blood sugar, which can lead to meaningful weight loss when combined with lifestyle changes like diet and exercise. This guide explains how to get Wegovy, who qualifies, what to expect from the process, and what to consider before starting treatment.
Eligibility and Medical Criteria for Wegovy
To qualify for Wegovy, clinicians assess body weight metrics and health history. Eligibility typically requires a BMI of 30 or higher (obesity) or a BMI of 27 or higher with at least one weight-related comorbidity. A qualified healthcare professional will review your medical history, current medications, and any prior weight-loss attempts. Conditions such as uncontrolled hypertension, cardiovascular disease, or certain endocrine disorders may affect suitability, and pregnancy or plans to become pregnant are absolute contraindications, as semaglutide may harm a developing fetus.
Key Eligibility Criteria at a Glance
| Attribute | Verified Detail | Source Type |
|---|---|---|
| BMI threshold for obesity | 30 or higher | Label guidance |
| BMI threshold with comorbidities | 27 or higher with at least one weight-related condition | Label guidance |
| Active pregnancy | Contraindicated | Label guidance |
| Personal history of medullary thyroid cancer or MEN 2 | Contraindicated | Label guidance |
| Severe gastrointestinal disease | Precaution; use may be limited | Prescribing information |
Consult a Healthcare Provider to Confirm Suitability
Because Wegovy is a prescription medication, you need a clinician’s assessment to determine if it’s safe and appropriate for you. Start by scheduling an appointment with your primary care physician, an endocrinologist, or a weight-management specialist. Bring details about your health history, current medications, and previous weight-loss efforts. Ask about potential benefits, risks, and how Wegovy fits into a broader plan that includes nutrition, physical activity, and behavioral support. This consultation is the essential first step in the process of how to get Wegovy.
What to Prepare for Your Appointment
- Current weight, height, and recent lab results (e.g., HbA1c, lipid panel)
- List of prescription and over-the-counter medications, including supplements
- Notes on your diet, activity level, and weight history
- Questions about dosing, side effects, and cost/insurance coverage
The Prescription and Access Process
Wegovy is administered as a once-weekly subcutaneous injection, starting at a low dose and gradually titrating under medical supervision to minimize gastrointestinal side effects. Your clinician will write a prescription, which you can take to a retail pharmacy or a mail-order service approved for dispensing weight-management therapies. Many telehealth platforms now offer virtual consultations with clinicians who can prescribe Wegovy and coordinate shipping to your home, which can be convenient for ongoing refills. However, in-person visits may be required for initial prescriptions, dose adjustments, or if you have complex medical needs.
Prescription and Access Workflow
- Complete a medical evaluation with a qualified clinician.
- Receive a prescription if deemed appropriate, including dose instructions.
- Present the prescription at a pharmacy or use an authorized mail-order service.
- Follow up regularly for dose titration, monitoring, and ongoing support.
Cost, Insurance, and Savings Options
Wegovy can be expensive without insurance, so it’s important to confirm coverage early. Many health plans, including Medicare Part D and some employer-sponsored plans, cover semaglutide when it is medically necessary, but requirements like prior authorization and step therapy may apply. Contact your insurer with the J-code for semaglutide (typically J7463 or as updated on your plan) to verify benefits. If you face high out-of-pocket costs, Novo Nordisk, the manufacturer, offers savings cards, copay assistance, and patient support programs that can lower your expenses significantly.
Typical Cost and Insurance Considerations
| Metric | Estimate or Range | Context |
|---|---|---|
| Average monthly cost without insurance | $1,300–$1,500 | List price may vary by pharmacy and region |
| Typical patient copay with insurance | $0–$100 per month | Depends on plan design and prior authorization status |
| Eligibility for manufacturer savings programs | Available for eligible insured and uninsured patients | Participation and income requirements apply |
Alternatives and Complementary Approaches
If Wegovy isn’t accessible or suitable, several alternatives exist. Other GLP-1 receptor agonists, such as Ozempic (semaglutide for type 2 diabetes) and Mounjaro (tirzepatide, a dual GIP/GLP-1 agonist), may be prescribed off-label for weight loss under medical supervision. Non-medication strategies—structured calorie control, increased physical activity, meal replacements, and behavioral therapy—can also produce meaningful weight loss. For some individuals, bariatric surgery may be an option if conservative measures are insufficient. Always discuss alternatives with your clinician to choose the safest and most effective approach for your health profile.
Safety, Side Effects, and Monitoring
Common side effects of Wegovy include nausea, vomiting, diarrhea, constipation, and abdominal pain, especially when doses are increased. These often improve over time but can be managed by dose titration and eating smaller, balanced meals. Rare but serious risks include pancreatitis, gallbladder problems, and changes in kidney function. Regular follow-ups allow your clinician to monitor lab values, adjust treatment, and address concerns early. Report any severe or persistent symptoms promptly to ensure safe, effective use of Wegovy.
Lifestyle Support to Maximize Results
Medication works best when paired with sustainable lifestyle changes. Aim for a reduced-calorie, nutrient-dense diet rich in vegetables, lean proteins, whole grains, and healthy fats, and incorporate at least 150 minutes of moderate-intensity activity per week. Behavioral strategies—such as self-monitoring, goal-setting, and peer or professional support—can improve adherence and outcomes. Many clinics offer structured programs that combine medical therapy with dietitians, exercise specialists, and mental health professionals to support long-term weight management.
Where to Get Started and Helpful Resources
To begin, schedule a visit with your primary care provider or a weight-management specialist, or use a telehealth platform that offers virtual prescribing for GLP-1 medications. Bring your health metrics and questions to make the consultation efficient. Additional resources include patient education materials from Novo Nordisk, insurer benefit lookup tools, and reputable programs like Diabetes Self-Management Education and Support (DSMES) or evidence-based weight-loss programs. Using this roadmap on how to get Wegovy, you can navigate eligibility, access, and safety with confidence.